Get an alert when PROPHARMA GROUP MIS LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-29 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-11-18 (in 6mo)

Last made up 2025-11-04

Watchouts

None on the register

Cash

£1M

Latest balance sheet

Net assets

£20M

Equity attributable

Employees

535

Average over period

Profit before tax

£2M

Period ending 2024-12-31

Name history

Renamed 1 time since incorporation

  1. PROPHARMA GROUP MIS LIMITED 2015-10-04 → present
  2. PROFESSIONAL INFORMATION LIMITED 1998-11-20 → 2015-10-04

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £55,930,836£60,683,867
Operating profit -£4,861,444£1,765,928
Profit before tax -£4,831,421£1,797,117
Net profit -£4,336,829£1,797,117
Cash £978,739£1,394,355
Total assets less current liabilities £17,904,232£19,701,349
Net assets £17,865,489£19,662,606
Equity £17,865,489£19,662,606
Average employees 556535
Wages £25,519,146£28,245,249

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin -8.7%2.9%
Net margin -7.8%3.0%
Return on capital employed -27.2%9.0%
Current ratio 1.32x1.20x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Auditor
RSM UK Audit LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors have prepared forecasts the period to 12 months from the date of approval of the financial statements and obtained confirmation of support from the ultimate parent company. As a result, at the time of approval of the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue existence for at least twelve months. Thus, the directors continue to adopt going concern basis of accounting in the preparation of the financial statements.”

Group structure

  1. PROPHARMA GROUP MIS LIMITED · parent
    1. Propharma Group MIS Pty Ltd 100% · Australia · Provision of medical information services
    2. Planet Pharma Group Limited 100% · United Kingdom · Provision of recruitment services

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 15 resigned

Name Role Appointed Born Nationality
BARKER, Carl Director 2024-09-05 Mar 1986 British
DEGOES, Jason Jon Director 2021-02-15 Nov 1969 American
Show 15 resigned officers
Name Role Appointed Resigned
DEONANAN, Karl Secretary 2023-07-15 2024-08-28
GRAEME, Dorothy May Nominee Secretary 1998-11-20 1998-11-20
LILLEY, Keith Douglas Secretary 1998-11-20 2015-09-30
SHERMAN, Dawn Gail Secretary 2019-01-24 2023-07-15
BAUWENS, Timothy Joseph Director 2021-07-02 2024-04-29
CHESTNUT, Robert Hugh Director 2014-01-03 2021-07-02
DEONANAN, Karl Vishnu Director 2023-07-15 2024-08-28
FEAGANS, Derek Everett Director 2018-07-06 2018-10-31
GRAEME, Lesley Joyce Nominee Director 1998-11-20 1998-11-20
HARGROVES, Thomas Jeffrey Director 2014-01-03 2018-07-06
HOFFMAN, Kirk Director 2014-01-03 2018-07-06
LILLEY, Keith Douglas Director 1998-11-20 2015-09-30
LILLEY, Rachel Anne Director 1998-11-20 2015-09-30
LUIJENDIJK, Jan Johannes Director 2019-01-24 2021-01-31
SHERMAN, Dawn Gail Director 2018-07-06 2023-07-15

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Mr Thomas Jeffrey Hargroves Individual Significant influence 2016-11-20 Ceased 2018-07-06
Propharma Group Mis Holdings Limited Corporate entity Shares 75–100% 2016-11-20 Active

Filing timeline

Last 20 of 132 total filings

Date Type Category Description
2026-03-17 AA accounts Accounts with accounts type full
2025-12-29 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2025-12-19 AA01 accounts Change account reference date company previous shortened PDF
2025-11-04 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-02-24 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-12-20 AA accounts Accounts with accounts type full
2024-09-10 AP01 officers Appoint person director company with name date PDF
2024-09-04 TM01 officers Termination director company with name termination date PDF
2024-09-04 TM02 officers Termination secretary company with name termination date PDF
2024-05-07 TM01 officers Termination director company with name termination date PDF
2024-02-09 AA accounts Accounts with accounts type full
2023-12-22 AA01 accounts Change account reference date company previous shortened PDF
2023-12-22 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-10-27 CH01 officers Change person director company with change date PDF
2023-10-27 CH03 officers Change person secretary company with change date PDF
2023-10-23 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2023-07-24 AP03 officers Appoint person secretary company with name date PDF
2023-07-24 AP01 officers Appoint person director company with name date PDF
2023-07-24 TM01 officers Termination director company with name termination date PDF
2023-07-24 TM02 officers Termination secretary company with name termination date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
4

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Year-on-year comparison hidden: this filing's period length differs materially from the prior year.

Official Companies House page